Levocetirizine oral films

Levocetirizine oral films

Levocetirizine oral films

Levocetirizine (as levocetirizine dihydrochloride) is a third-generation non-sedative antihistamine, developed from the second-generation antihistamine cetirizine. Chemically, levocetirizine is the active enantiomer of cetirizine. It is the L-enantiomer of the cetirizine racemate.

Levocetirizine works by blocking histamine receptors. It does not prevent the actual release of histamine from mast cells, but prevents it binding to its receptors.

This in turn prevents the release of other allergy chemicals and increased blood supply to the area, and provides relief from the typical symptoms of hayfever.

The manufacturers claim it to be more effective with fewer side effects than the second-generation drugs; however, there have been no published studies supporting this assertion, although other studies have concluded it may be more effective.

Available Form:

Levocetirizine DI HCL Films

We also offer Sustained (SR) / Immediate (IR) / Timed (TR) / Controlled (CR) / Delayed Release (DR) and Enteric Coated (EC).

Therapeutical:

Antiallergic

Dosage:

Levocetirizine 2 mg

Solutions from us:

  • Making process suitability for your products.
  • Deciding the right kind of technology / equipments for the products.
  • Process Validation & Stability.
  • Documentation.
  • Technology transfer of products with complete line of equipments.
  • Doessair preparation.
  • Validation and regulatory support.

Levocetirizine
Systematic (IUPAC) Name
Levocetirizine
Identifiers
Levocetirizine
Chemical data
2-(2-{4-[(R)-(4-chlorophenyl)(phenyl)methyl]piperazin-1-yl}ethoxy)acetic acid
CAS number : 130018-77-8
ATC code : R06AE09
PubChem : CID 1549000
IUPHAR ligand : 1214
ChemSpider : 1266001
UNII : 6U5EA9RT2O
KEGG : D07402
ChEMBL : CHEMBL1201191
Formula : C21H25ClN2O3
Mol. mass : 388.888 g/mol

* All transactions are carried out in conformity with patent laws applicable in the user country. Active pharmaceutical ingredients or formulations thereof will not be supplied in countries where the same is under patent protection except as and if permitted under law of the country for research and development purposes only.

0